SCYNEXIS Inc. is currently addressing a regulatory compliance issue related to the Nasdaq minimum bid price requirement. The company has been granted a 180-day extension by Nasdaq to raise its share price to at least $1.00 per share for a minimum of ten consecutive business days. Failure to meet this requirement could impact SCYNEXIS’s continued listing on the Nasdaq Capital Market. The company has stated its intention to take all necessary actions, including a potential reverse stock split, to regain compliance within the extension period. No other regulatory issues or tariffs are mentioned as impacting the company at this time.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SCYNEXIS Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9605548) on December 22, 2025, and is solely responsible for the information contained therein.
Comments